Spinal Tech

Here are seven key notes from orthopedic and spine device companies in the past week.

Needham shifted its stock ratings for Medtronic and Zimmer Biomet, according to Seeking Alpha.

OrthoPediatrics is moving forward with plans to expand its Warsaw, Ind.-based headquarters.

7D Surgical received 510(k) clearance from the FDA for its Cranial Module, a step toward launching the company's Machine-vision Image Guided Surgery system for cranial surgery throughout the U.S., according to Markets Insider.

The FDA cleared 28 spine-related devices in July 2018.

UBS downgraded Smith & Nephew's stock from "neutral" to "buy" after apprehensions about the company's control over the surgical robots market, according to Proactive Investors.

The global interbody fusion cage market is projected grow at a 3.4 percent compound annual growth rate to reach $2.31 billion by 2023, according to a ResearchAndMarkets.com report.

Paul Leake is the co-founder and managing director of VerteCore Technologies, a medical device company that develops mobile decompression devices for the orthopedic market.

A new Transparency Market Research report estimates the wearable devices market, including wearable vital sign monitors and obstetric devices, will be worth $10 billion by the end of 2023.

Infiniti Research, a market intelligence solutions provider, outlined the medical reimbursement challenges medical device companies face.